Related Experiment Videos
[Oral antidiabetic drugs]
1Service de diabétologie, maladies métaboliques et nutrition Centre hospitalier universitaire Rangueil, Toulouse.
Abstract:
Type II diabetes includes various pathophysiologic entities. Glycoregulatory disorders are due to multiple mechanisms, associated to different degrees. Identical response to treatment is not observed among patients or at different times of treatment, early or later in the disease. Until very recently, the treatment available was insufficient. It now has gained new classes of drugs that act on the secretion of insulin, the sensitivity to insulin and the rate of intestinal glucide absorption. Approaches to treatment are often complementary and oral antidiabetic drugs can be associated. Hygienic and dietary measures remain indispensable to reinforce drug efficacity and to prevent complications in these patients.
Insights
Type II diabetes involves complex glycoregulatory disorders with varied patient responses to treatment. New drug classes and lifestyle changes improve management and prevent complications.
Area of Science:
- Endocrinology and Metabolism
- Pharmacology
Context:
- Type II diabetes presents diverse pathophysiologic mechanisms.
- Patient responses to diabetes treatments vary significantly over time and between individuals.
- Historically, insufficient treatment options were available for managing Type II diabetes.
Purpose:
- To review the evolving landscape of Type II diabetes treatment.
- To highlight new therapeutic classes and their mechanisms of action.
- To emphasize the importance of integrated treatment approaches.
Summary:
- Recent advancements have introduced novel drug classes targeting insulin secretion, insulin sensitivity, and intestinal glucose absorption.
- These new pharmacological options offer complementary approaches, often used in combination with existing oral antidiabetic drugs.
- Lifestyle interventions, including diet and exercise, remain crucial for enhancing drug efficacy and preventing long-term complications.
Impact:
- Improved therapeutic options for managing Type II diabetes.
- Potential for better glycemic control and reduced disease progression.
- Reinforces the necessity of personalized treatment strategies and comprehensive patient care.